Rice Hall James & Associates, LLC Castle Biosciences Inc Transaction History

Rice Hall James & Associates, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	BUY	$16.0 - $45.99 $9,584 - $27,548	599 Added 2.29%	26,750 $587,000
Q1 2022 May 05, 2022	BUY	$33.17 - $46.98 $31,113 - $44,067	938 Added 3.72%	26,151 $1.17 Million
Q4 2021 Feb 14, 2022	SELL	$39.06 - $67.58 $137,920 - $238,624	-3,531 Reduced 12.28%	25,213 $1.08 Million
Q3 2021 Nov 09, 2021	SELL	$60.13 - $77.6 $336,307 - $434,016	-5,593 Reduced 16.29%	28,744 $1.91 Million
Q2 2021 Jul 29, 2021	SELL	$50.07 - $76.78 $74,203 - $113,787	-1,482 Reduced 4.14%	34,337 $2.52 Million

Q1 2021 May 14, 2021	BUY	$58.92 - $97.33 $648 - $1,070	11 Added 0.03%	35,819 $2.45 Million
Q4 2020 Feb 16, 2021	BUY	$43.6 - $73.05 $103,201 - $172,909	2,367 Added 7.08%	35,808 $2.41 Million
Q3 2020 Nov 16, 2020	BUY	$38.47 - $52.03 $407,589 - $551,257	10,595 Added 46.38%	33,441 $1.72 Million
Q2 2020 Aug 14, 2020	BUY	$27.28 - $43.01 $7,802 - $12,300	286 Added 1.27%	22,846 $861,000
Q1 2020 May 15, 2020	BUY	$23.08 - $35.53 $520,684 - $801,556	22,560 New	22,560 $673,000

162

25.3M

82.2K

150K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $559M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

Stay updated on Rice Hall James & Associates, LLC with notifications on news.